Last 138.50 GBp
Change Today -0.25 / -0.18%
Volume 82.8K
VEC On Other Exchanges
As of 11:35 AM 07/11/14 All times are local (Market data is delayed by at least 15 minutes).
text size: T | T
Back to Snapshot
Company Description

Contact Info

One Prospect West

Chippenham, SN14 6FH

United Kingdom

Phone: 44 1249 667700

Fax: 44 1249 667701

Vectura Group plc develops pharmaceutical therapies for the treatment of bronchopulmonary diseases. Its products target various diseases, such as asthma and chronic obstructive pulmonary disease (COPD). The company offers ADVATE, a serum-free recombinant factor VIII for haemophilia A; Adept, a 4% icodextrin solution used during surgery to reduce post-surgical adhesions; Extraneal, a solution containing icodextrin for peritoneal dialysis; and Seebri Breezhaler, a long-acting muscarinic antagonist for the treatment of COPD, as well as Asmasal Clickhaler, Asmabec Clickhaler, and Meptin for the treatment of asthma. Its product pipeline comprises QVA149, a fixed-dose combination of indacaterol maleate and glycopyrronium bromide for the treatment of adult patients with COPD; VR315 and VR632 that are inhaled combination therapies for asthma and COPD; VR506, an inhaled corticosteriod for the treatment of asthma; VR496, an inhaled, locally acting treatment for symptoms of inflammatory respiratory disease; and VR040, an inhaled, systemically acting form of apomorphine hydrochloride for treating off episodes associated with advanced Parkinson's disease. The company also provides various drug delivery technology platforms, such as PowderHale, a dry powder inhalation (DPI) formulation technology that is designed to allow aerosolized drug particles to achieve high lung deposition with low-dose variability; GyroHaler and OmniHaler, which are multi-unit dose DPI devices designed to deliver locally acting drugs to the lungs; Clickhaler, a single-dose inhaler; and Duohaler, a dry powder inhaler. It has development collaborations and license agreements with Novartis AG, Sandoz, Baxter International Inc, GlaxoSmithKline, and Tianjin KingYork Group Company Limited. The company was founded in 1997 and is headquartered in Chippenham, the United Kingdom.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
VEC:LN 138.50 GBp -0.25

VEC Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Skyepharma PLC 247.75 GBp -1.25
View Industry Companies

Industry Analysis


Industry Average

Valuation VEC Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 13.2x
Price/Book 2.5x
Price/Cash Flow 124.3x
TEV/Sales 15.6x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact VECTURA GROUP PLC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at